New and emerging treatments for major depressive disorder.
BMJ (Clinical research ed.) July 8, 2024 Cecilia Njenga, Parashar Pravin Ramanuj, Frederico José Coelho de Magalhães et al. 44 citations
Major depressive disorder (MDD) affects a substantial portion of the population; however, much is still unknown about the pathophysiology of this disorder. Treatment resistance highlights the heterogeneous nature of MDD and the need for treatments to target more than monoamine neurotransmission. This review summarizes research into the new and emerging targets of MDD. These include drugs such...